2019
| Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial | 24.06.2019 (Mihaela Sava) Chen M et al.: Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial Lancet Infect Dis 2019 published online June 10 2019 |
| Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing | 03.06.2019 (Jacopo Nicoletti) Bellew S. et al.: Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing Clin. Infect. Dis. 68 2026-2033 |
| Antibacterial Envelope to Prevent Cardiac Implantable Device Infection | 27.05.2019 (Brian Duggan) Tarakji KG et al.: Antibacterial Envelope to Prevent Cardiac Implantable Device Infection N Engl J Med. 380 1895-1905 |
| Should Acute Q-Fever Patients be Screened for Valvulopathy to Prevent Endocarditis? |
|
| Decontamination Strategies and Bloodstream Infections with Antibiotic-Resistant Microorganisms in Ventilated Patients - A Randomized Clinical Trial | 13.05.2019 (Ana Durovic) Bastian H. Wittekamp et al.: Decontamination Strategies and Bloodstream Infections with Antibiotic-Resistant Microorganisms in Ventilated Patients - A Randomized Clinical Trial JAMA 320(20) 2087-2098. |
| Clinical Data on Daptomycin plus Ceftaroline vs standard of Care Monotherapy in the treatment of MRSA bacteremia | 06.05.2019 (Sandra Zingg) Geriak M. et al: Clinical Data on Daptomycin plus Ceftaroline vs standard of Care Monotherapy in the treatment of MRSA bacteremia Antimicrob Agents Chemother 63 E02483-18 2019 |
| Hardwiring diagnostic stewardship using electronic ordering restrictions for gastrointesetinal pathogen testing | 29.04.2019 (Andrea Büchler) Marcelin JR et al.: Hardwiring diagnostic stewardship using electronic ordering restrictions for gastrointesetinal pathogen testing Infection Control & Hospital Epidemiology 1-6 2019 |
| An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised tria | 08.04.2019 (Matthias von Rotz) Mitchell BG. et al. An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial Lancet Infect Dis 19: 410-18 2019 |
| Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial | 01.04.2019 (Sabine Kuster) Kokai-Kun J. et al.: Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial Lancet Infect Dis Published Online March 15, 2019 |
| HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation |
|
| Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients | 04.03.2019 (Veronika Bättig) Satlin MJ et al.: Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients Clin Infect Dis. 67 1720-1728 2018 |
| Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy | 25.02.2019 (Elisabeth Wehrle) Bremmer D.N. et. Al.: Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy CID 68 725-30 2019 |
| Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial | 18.02.2019 (Jacopo Nicoletti) Yahav D. et al.: Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial Clin. Infect. Dis. ePub 11.12.2018 |
| Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis |
|
| Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumonia Carbapenemase-producing K. pneumoniae | 28.01.2019 (Sabine Kuster) Tumbarello M. et al: Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumonia Carbapenemase-producing K. pneumoniae CID Volume 68-3 355-64 2019 |
| A prospective study of transmission of Multidrug-Resistant Organisms (MDROs) between environmental sites and hospitalized patients – the TransFER study | 21.01.2019 (Andrea Büchler) Chen F. et al: A prospective study of transmission of Multidrug-Resistant Organisms (MDROs) between environmental sites and hospitalized patients – the TransFER study ICHE 40 47-52 2019 |
| Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial | 14.01.2019 (Niklaus Labhardt) Jung-Kyu Lee et al.: Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial Lancet Infect Dis 19 46-55 2019 |
Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis | 07.01.2019 (Matthias von Rotz) Tricco AC et al. : Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis BMJ 363:k4029 2018 |